A risk stratification analysis of atherosclerotic cardiovascular disease events post-statin discontinuation in patients who underwent sleeve gastrectomy or Roux-en-Y gastric bypass bariatric/metabolic surgeries.
Abdulrahman A AlsuhibaniAzzam Al-KadiPatricia R WigleJeff Jianfei GuoAlex C LinMarepalli B RaoAna L HincapiePublished in: Surgery (2024)
Post-bariatric surgery statin discontinuation can pose significant risks, especially for those with atherosclerotic cardiovascular disease history and certain demographic groups, such as those over age 40 with diabetes. Ethnic disparities in outcomes necessitate individualized, equitable healthcare strategies. Optimal decisions about statin cessation necessitate comprehensive evaluations of cardiovascular determinants, with future research crucial to refine therapeutic approaches based on these insights.
Keyphrases
- cardiovascular disease
- roux en y gastric bypass
- weight loss
- bariatric surgery
- obese patients
- gastric bypass
- healthcare
- end stage renal disease
- type diabetes
- cardiovascular events
- cardiovascular risk factors
- newly diagnosed
- coronary artery disease
- chronic kidney disease
- ejection fraction
- prognostic factors
- glycemic control
- metabolic syndrome
- current status
- climate change
- human health
- health information
- patient reported outcomes